Impel Pharmaceuticals
Healthcare
HQ: Seattle, United States
Investors: 1
Late-stage biopharmaceutical company that optimizes drug delivery for central nervous system diseases using its proprietary nasal drug delivery technology
Late-stage biopharmaceutical company that optimizes drug delivery for central nervous system diseases using its proprietary nasal drug delivery technology